Balanced news tone
News Sentiment
688796 sentiment intelligence
BIOCYTOGEN PHARMACEUTICALS (BEI news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
3 relevant articles
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+5.7% over one week, -9.9% over four weeks, trend inactive, and near fair-value range.
Biocytogen Pharmaceuticals Co., Ltd.(XSSC: 688796) added to S&P Global BMI Index
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
78/100 classification
One-week reaction
5.7%
Price confirming higher
Trend fit
Trend inactive
-9.9% over four weeks
Fair value
14.2%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
3
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
Biocytogen Pharmaceuticals Co., Ltd.(XSSC: 688796) added to S&P Global BMI Index
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 02:15
- Source
- marketscreener.com
Business Wire
Direct company coverage
Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Mar 2026 07:00
- Source
- Business Wire
Business Wire
Direct company coverage
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Dec 2025 08:00
- Source
- Business Wire